SenseLab 
logo Brain Pharmacology Database User:Public
[Data]
Pathological mechanism
NameAbeta (1-42) increases dopamine release in the prefrontal cortex
Description
Hypothesis
Nicotinic Receptor Hypothesis show other
Extracelular pathological element
Beta-amyloid (1-42) show other
Intracelular pathological element
Pathological action
Increases show other
Process
Process action
Transmitter(s)
Dopamine show other
Receptor(s)
Channel(s)
Pharmacological Agent
alpha7 nicotinic receptor antagonists show other
Pharmacological Action
Blocks show other
Brain region
Neuron
Cell model
Cellular compartment
PubMed ID17935702
Citation
AlzWeb
NotesIn the presence of tetrodotoxin, Abeta(1-42) at 100 nM evoked the release of dopamine to approximately 170% of basal levels in the pre-frontal cortex. The Abeta(1-42)-evoked dopamine release was sensitive to antagonists of alpha7 nicotinic receptors.
Pathology
Stage
Question
Claim

Other categories referring to "Abeta (1-42) increases dopamine release in the prefrontal cortex"

 
Revisions:3
Last time:7/31/2008 11:59:51 AM
Reviewer:Pradeep Mutalik
Owner:Pradeep Mutalik

This database was supported by the Human Brain Project (NIDCD, NIMH, NIA, NICD, NINDS) and MURI (Multidisciplinary University Research Initiative). It is now supported by RO1 DC 009977 from the National Institute for Deafness and other Communication Disorders.
Link Graphic to NIF website Human Brain Project Yale Center for Medical Informatics Questions, comments, problems? Email the Database Administrator
This site is Copyright 2011, Yale Center for Medical Informatics
National Institutes of Health Department of Health and Human Services